Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound
Repeatability and Reproducibility of Pachymetric Mapping With Fourier Domain Optical Coherence Tomography, Ocular Response Analyzer, Confoscan 4 and Ultrasound
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of this study is to assess the repeatability, reproducibility, and agreement of central corneal thickness measured by Fourier Domain Optical Coherence tomography (FD-OCT, OptoVue, USA) with anterior corneal module, 20MHz ultrasound pachymetry equipped with Ocular response analyzer (ORA, Reichert Ophthalmic Instruments, USA) and 10MHz Ultrasound Pachymetry (USP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 4, 2009
CompletedFirst Posted
Study publicly available on registry
February 6, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFebruary 6, 2009
February 1, 2009
7 months
February 4, 2009
February 5, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
Repeatability and reproducibility of corneal thickness measurement
3 months
Secondary Outcomes (1)
Comparing central corneal thickness measurement among FD-OCT, ORA, and USP
3 months
Study Arms (1)
FD-OCT, ORA, USP
Eligibility Criteria
Healthy volunteer who has no prior ocular disease history and prior intraocular surgical history
You may qualify if:
- Healthy Volunteers
You may not qualify if:
- Patients who had history of prior ocular surgery, ocular abnormalities other than cataract or refractive error or were unable to cooperate in the examination were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial Hospital
Banqiao District, Taipei, 220, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shu-Wen Chang, MD
Far Eastern Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 4, 2009
First Posted
February 6, 2009
Study Start
June 1, 2008
Primary Completion
January 1, 2009
Study Completion
June 1, 2009
Last Updated
February 6, 2009
Record last verified: 2009-02